Long‐term outcome after <scp>COVID</scp>‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study

Abstract

Long-term outcome of COVID-19 is favourable in a large majority of pwMS with only a small proportion of patients suffering from persistent symptoms usually resolving after 3-6 months. COVID-19 is not associated with increased risk of relapse or disability.